Neurologic erectile dysfunction

Urologic Clinics of North America

Volumn 28, Issue 2, 2001, Pages 289-308

  Nehra, Ajay ^a   Moreland, Robert B ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; CYCLODEXTRIN; MEDICATED URETHRAL SYSTEM FOR ERECTION; PAPAVERINE; PHENTOLAMINE; PROSTAGLANDIN E1; PROSTAVASIN; SILDENAFIL; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALZHEIMER DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DEVICE; DIABETES MELLITUS; EPILEPSY; ERECTILE DYSFUNCTION; GRIEF; HEALTH EDUCATION; HUMAN; LEPROSY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATIENT SATISFACTION; PENIS ERECTION; PENIS PROSTHESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; PSYCHOTHERAPY; REVIEW; SPINA BIFIDA; SPINAL CORD INJURY;

EID: 0034981703     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70139-7     Document Type: Article

References (203)

1. Apoptosis in the erectile tissue of diabetic and healthy rats
2. Nerve growth factor enhances peripheral nerve regeneration in nonhuman primates
3. Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration
4. Noninvasive treatment for erectile dysfunction in the neurogenically disabled population
5. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction
6. Clinical approach to the sexuality of patients with spinal cord injury
7. Neurophysiological evaluation of sexual dysfunction in familial amyloidotic polyneuropathy-Portuguese type
8. Impotence in the low-back syndrome
9. The effect of sildenafil on apomorphine-evoked increases in intracavernous pressure in the awake rat
10. Physiology of erection
11. Genitourinary disturbances in familial and sporadic cases of primary amyloidosis with polyneuropathy
12. Neurotrophic factors in the therapy of diabetic neuropathy
13. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy: NGF Study Group
14. New developments in the diagnosis of diabetic neuropathy
15. Nitric oxide and penile erection in streptozotocin-diabetes rats
16. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle
17. The effect of adenovirus mediated brain derived neurotropic factor in an animal model for neurogenic impotence
18. Late neurological dysfunction in adult lumbosacral lipoma with tethered cord
19. Neurophysiological testing in erectile dysfunction
20. Genitourinary dysfunction in multiple system atrophy: Clinical features and treatment in 62 cases
21. Oxidative stress and S-nitrosylation of proteins
22. Male sexual impotence in diabetes: Vasculogenic versus neurogenic factors
23. Bulbocavernous reflex studies and autonomic testing in the diagnosis of erectile dysfunction
24. Impotence associated with the Charcot-Marie-Tooth syndrome
25. Dysfunctional penile cholinergic nerves in diabetic impotent men
26. Sex inventories: Can questionnaires replace erectile dysfunction testing?
27. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury
28. Tethered spinal cord: The effect of neurosurgery on the lower urinary tract and male sexual function
29. Pathology of disulfram neuropathy
30. Evidence based assessment of erectile dysfunction
31. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat
32. Complications of penile prostheses and complex implantations
33. Selective nitrergic neurodegeneration in diabetes mellitus - A nitric oxide-dependent phenomenon
34. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction
35. Gonadal dysfunction in mitochondrial encephalomyopathies
36. Recombinant human glial growth factor 2 (rhGGF2) improves functional recovery of crushed peripheral nerve (a double-blind study)
37. Early relief of erectile dysfunction after laser decompression of herniated lumbar disc
38. Neurophysiology of penile erection
39. Familial amyloid polyneuropathy: New developments in genetics and treatment
40. Autonomic nerve involvement and venous leakage in diabetic men with impotence
41. Efficacy and safety of transurethral alprostadil in patients with erectile dysfunction following radical prostatectomy
42. Clinical approach to erectile dysfunction in spinal cord injured men: A review of clinical and experimental data
43. Post-traumatic erectile potential of spinal cord injured men: How physiologic recordings supplement subjective reports
44. Abnormal nerve conduction in impotent patients with diabetes mellitus
45. Improved nerve regeneration with neutralization of transforming growth factor beta 1
46. Damage to the erectile function following radical pelvic surgery: Prevalence of veno-occlusive dysfunction
47. Vacuum erection device in spinal cord injured men: Patient and partner satisfaction
48. Effect of intensive diabetes management on the development and progression of neuropathy
49. Techniques in primary nerve repair
50. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: A multicentre double-blind placebo-controlled study
51. Alterations of sexual behavior in temporal lobe epilepsy
52. Possible molecular mechanisms of cryoablation-induced impotence in a rat model
53. Effect of cavernous nerve freezing on protein and gene expression of nitric oxide synthase in the rat penis and pelvic ganglia
54. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model
55. Bulbocavernous-reflex latencies and pudendal nerve SSEP compared to penile vascular testing in 669 patients with erectile failure and other sexual dysfunction
56. Injury-induced gelatinase and thrombin-like activities in regenerating and non-regenerating nervous systems
57. Multiple system atrophy following chronic carbon disulfide exposure
58. Acute cauda equina syndrome secondary to lumbar disc herniation mimicking pure conus medullaris syndrome - Case report
59. Unusual complications of the vacuum erection device
60. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E
61. Unifying features of systemic and cerebral amyloidosis
62. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury: Sildenafil Study Group
63. Neural control of penile erection
64. Oral sildenafil in the treatment of erectile dysfunction: Sildenafil Study Group
65. Neurourologic abnormalities in multiple sclerosis
66. Two distinct mechanisms of nitric oxide-mediated neuronal cell death show thiol dependency
67. Glycemic control and nerve conduction abnormalities in non-insulin dependent diabetic subjects
68. Diabetic neuropathy: Scope of the syndrome
69. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double-blind placebo-controlled trial with clomiphene citrate
70. Nocturnal penile tumescence and rigidity evaluation in men with epilepsy
71. Diabetic sexual dysfunction
72. Seizure control with clomiphene therapy: A case report
73. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin
74. Impotence in patients with temporal-lobe lesions
75. 1 for neuropathic erectile dysfunction
76. Diabetes, erectile dysfunction and sleep-related erections
77. Corino-Andrade disease (familial amyloidotic polineuropathy type I) in Spain: Urological and andrological disorders
78. Shy-Drager syndrome
79. Endothelin: Emerging role in diabetic vascular complications
80. Improved sexual function in three men taking lamotrigine for epilepsy
81. Age-related increase in an advanced glycation end product in penile tissue
82. IGF-I and TGF-beta2 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats
83. Growth hormone enhances regeneration of nitric oxide synthase-containing penile nerves after cavernous nerve neurotomy in rats
84. Insulin increases NO-stimulated guanylate cyclase activity in cultured VSMC while raising redox potential
85. Sildenafil citrate (Viagra) treatment in patients with diabetes mellitus
86. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy
87. Inherited peripheral neuropathy
88. Computerized classification of corpus cavernosum electromyogram signals by the use of discriminant analysis and artificial neural networks to support diagnosis of erectile dysfunction
89. Immediate sexual rehabilitation by simultaneous placement of penile prosthesis in patients undergoing radical prostatectomy: Initial results in 50 patients
90. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections
91. Damage-induced neuronal endopeptidase (DINE) is a unique metalloproteinase expressed in response to neuronal damage and activates superoxide scavengers
92. Prevalence of self-reported erectile dysfunction in people with long-term IDDM
93. Neurostimulation during radical prostatectomy: Improving nerve-sparing techniques
94. Early experience with intra-operative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy
95. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats
96. The intercostal to phrenic nerve transfer: An effective means of reanimating the diaphragm in patients with high cervical spine injury
97. Sexual adjustment after spinal cord injury (SCI) focusing on partner's experiences
98. Sexual dysfunction in Parkinson's disease
99. Sexual problems in patients suffering from multiple sclerosis
100. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
101. Potential preservation of potency after radical prostatectomy
102. Advances in spinal cord regeneration
103. Intraoperative electrostimulation of the cavernous nerve: Technique, results and limitations
104. Development of vascular complications in diabetes
105. Sexual dysfunction in the diabetic BB/WOR rat: A role of central neuropathy
106. Treatment of erectile dysfunction with sildenafil
107. About the neurological sequelae of herniated intravertebral disc
108. A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury
109. The influence of medication on erectile function
110. Diabetes and vascular impotence: Does insulin dependence increase the relative severity?
111. Diabetic impotence
112. A protein kinase C beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats
113. Male infertility and erectile dysfunction in spinal cord injury: A review
114. Drug-induced parkinsonism: A review
115. Clinical reliability of multidrug intracavernous vasoactive pharmacotherapy for diabetic impotence
116. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial
117. Sildenafil taken at bed-time significantly increases nocturnal erectile activity: Results of a prospective, Rigiscan study
118. Is there a role of hypoxemia in penile fibrosis: A viewpoint presented to the Society for the Study of Impotence
119. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor
120. New prospectives in the treatment of male erectile dysfunction
121. Long-term experience with salvage of infected penile implants
122. Erectile function after radical prostatectomy
123. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic preostatectomy
124. Nerve injury and regeneration: Basic insights and therapeutic interventions
125. Sex hormones and pituitary function in male epileptics with altered or normal sexuality
126. Pharmacotherapeutic advances in the treatment of erectile dysfunction
127. Sildenafil citrate (Viagra) after radical retropubic prostatectomy: Con
128. Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring noninvasive therapy: 18-Month follow-up
129. Vibratory stimulation and rectal probe electroejaculation as therapy for patients with spinal cord injury: Semen parameters and pregnancy rates
130. Male gonads in leprosy - A clinicopathological study
131. Vacuum devices for erectile impotence
132. Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met
133. Multiple sclerosis. Part I. Overview, pathophysiology, diagnostic evaluation, and clinical parameters
134. Apomorphine-induced penile erections in Parkinson's disease
135. Treatment of men with erectile dysfunction with transurethral alprostadil: Medicated Urethral System for Erection (MUSE) Study Group
136. The management of erectile dysfunction following spinal cord injury
137. Erectile dysfunction in spina bifida is treatable
138. Time-course of the alterations in prostanoid production and in contractile responses of mesenteric beds isolated from streptozotocin diabetic rats
139. Diabetes mellitus and its degenerative complications: A prospective study of 4400 patients observed between 1947 and 1973
140. Radical retropubic prostatectomy: The influence of accessory pudendal arteries on the recovery of sexual function
141. Effects of nerve growth factor on nerve regeneration through a vein graft across a gap
142. Autonomic neuropathy in leprosy
143. Spinal control of penile erection
144. Functional regeneration of sensory axons into the adult spinal cord
145. Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat
146. Intraoperative electrical stimulation of cavernosal nerves with monitoring of intracorporeal pressure in patients undergoing nerve sparing radical prostatectomy
147. Sildenafil for the treatment of erectile dysfunction in men with diabetes: A randomized controlled trial
148. Genitourinary disease in the elderly
149. Hormone profile in lepromatous leprosy: A preliminary study
150. Sexual function in men with diabetes type 2: Association with glycemic control
151. Process of care model for the management of erectile dysfunction in a primary care setting
152. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile function
153. Diabetic penile neuropathy
154. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
155. Pathophysiology of prolonged penile erection associated with trazodone use
156. Neurobiology of erectile dysfunction in multiple sclerosis
157. Impaired ascendant central nervous system pathways conduction in diabetic subjects
158. Central effects of sildenafil on intracavernous pressure (ICP) following electrical stimulation of the MPOA
159. Sutures alone are sufficient to support regeneration across a gap in the continuity of the sciatic nerve in rats
160. AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells
161. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS
162. A case of subacute idiopathic pan-dysautonomia recovery with prednisolone therapy
163. Neurophysiological approaches to the detection of neurotoxicity in humans
164. Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra)
165. Occult lumbar disk causing impotency
166. Spinal cord injury
167. Evaluation and nonsurgical management of erectile dysfunction
168. Parkinson's disease: A major hypokinetic basal ganglia disorder
169. Sexual function in patients with Parkinson's disease
170. Autonomic dysfunction in men with Parkinson's disease
171. Potency-preserving surgery
172. Intracavernosal therapy
173. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study
174. Use of nerve conduits in peripheral nerve repair
175. Cat peripheral nerve regeneration across 50-mm gap repaired with a novel nerve guide composed of a freeze-dried alginate gel
176. Midline prolapse of a lumbar intervertebral disc with compression of the cauda equina
177. Psychogenic impotence in spinal cord injury patients
178. Tissue specificity in rat peripheral nerve regeneration through combined skeletal muscle and vein graft conduits
179. Nerve growth factor (NGF) and diabetic neuropathy in the rat: Morphological investigations of the sural nerve, dorsal ganglion and spinal cord
180. Quality of life after radical prostatectomy
181. Sexual dysfunction in multiple sclerosis
182. Epidemiological study of the effects of carbon disulfide on male sexuality and reproduction
183. Sexual impotence and some autonomic disturbances in men with multiple sclerosis
184. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction
185. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients
186. Diabetic neuropathy: Pathogenesis and therapy
187. Urologic complications of major pelvic surgery
188. Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations
189. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy
190. Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in USA model spinal cord injury centers
191. Quantitative sensory and autonomic testing in male diabetic patients with erectile dysfunction
192. Clinical features and natural history of multiple system atrophy: An analysis of 100 cases
193. Radicals and oxidative stress in diabetes
194. Pathophysiology of tethered cord syndrome
195. A late onset familial amyloidotic polyneuropathy (FAP) with a novel variant transthyretin characterized by a basic for acidic substitution (Glu61>Lys)
196. Opposite influences of dopaminergic receptor subtypes on penile erection
197. A simplified pharmacologic erection program for patients with spinal cord injury
198. The incidence and correlates of erectile problems in patients with Alzheimer's disease
199. Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease
200. Role of Viagra after radical prostatectomy
201. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
202. Neurotrophins and other growth factors in the regenerative milieu of proximal nerve stump tips
203. Sexual dysfunction in multiple sclerosis: A case-control study. I. Frequency and comparison of groups